Palisade Capital Management LLC NJ cut its stake in shares of Elanco Animal Health Incorporat (NYSE:ELAT – Get Rating) by 3.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,251 shares of the company’s stock after selling 966 shares during the quarter. Palisade Capital Management LLC NJ’s holdings in Elanco Animal Health Incorporat were worth $1,251,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in the business. Loomis Sayles & Co. L P raised its stake in shares of Elanco Animal Health Incorporat by 12.8% during the fourth quarter. Loomis Sayles & Co. L P now owns 73,774 shares of the company’s stock worth $2,094,000 after acquiring an additional 8,389 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Elanco Animal Health Incorporat by 14.2% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 171,063 shares of the company’s stock worth $7,640,000 after acquiring an additional 21,321 shares in the last quarter. Finally, Wolverine Asset Management LLC raised its stake in shares of Elanco Animal Health Incorporat by 91.1% during the first quarter. Wolverine Asset Management LLC now owns 69,837 shares of the company’s stock worth $2,877,000 after acquiring an additional 33,284 shares in the last quarter.
Elanco Animal Health Incorporat Price Performance
ELAT stock opened at $31.61 on Friday. Elanco Animal Health Incorporat has a one year low of $30.38 and a one year high of $54.53. The company’s 50 day moving average price is $33.95 and its two-hundred day moving average price is $38.19.
Elanco Animal Health Incorporat Dividend Announcement
Featured Stories
- Get a free copy of the StockNews.com research report on Elanco Animal Health Incorporat (ELAT)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Elanco Animal Health Incorporat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health Incorporat and related companies with MarketBeat.com's FREE daily email newsletter.